01 · The Question
How Can You Keep Useful Companion Papers Without Counting the Same People Twice?
You identify a primary study report and then discover several related papers. One provides adverse-event data, another reports a secondary outcome, and a third contains long-term follow-up results. They all contain information your review could use.
Discarding the companion papers would lose potentially important evidence. Treating every paper as a separate independent study creates the opposite problem: the same participants may be represented repeatedly.
The solution is to separate two tasks that are easy to conflate. Use publications as sources of information, but organize that information around the underlying study and participant population. Cochrane explicitly recommends collating multiple reports of the same study rather than treating each report as another study.
03 · What You Need to Know
How to Separate Useful Information From Duplicate Participant Contributions
Start With the Study, Not the Paper
Systematic reviews commonly retrieve reports rather than neatly packaged studies. One study may be represented by a journal article, conference abstract, protocol, registry entry, secondary analysis, follow-up report, and other sources. Cochrane therefore treats the study, rather than each individual report, as the principal unit of interest.
Once you have established that several publications arise from the same investigation, assign them to a common study identifier. Each publication should retain its own report identifier so that you can trace exactly where information came from.
Study ID
Identifies the underlying investigation and connects all of its reports.
Report ID
Identifies the particular publication or source from which a piece of information was obtained.
This simple distinction prevents a common data-management problem: allowing the structure of your bibliography to dictate the structure of your evidence.
Companion Papers May Contain Information the Main Paper Does Not
A secondary report should not be discarded without examination. Cochrane notes that a single source rarely contains complete information about a study and specifically cautions that secondary reports may contain valuable information about study design, conduct, outcomes, and results.
A companion paper might provide:
an outcome omitted or abbreviated in the main report;
adverse events or harms;
longer-term follow-up;
details of intervention implementation;
a subgroup or secondary analysis;
additional information about methods or participant flow;
results for another measurement instrument; or
information that helps explain an apparent discrepancy elsewhere.
Using this information does not mean counting another study. You are enriching the record of the same underlying investigation.
Ask Whether the Same Participants Enter the Same Synthesis More Than Once
Double-counting becomes particularly consequential when two estimates based on the same participants are entered into one analysis as though they were independent.
Suppose a randomized trial of 500 participants produces two papers. Paper A reports depression using Scale X, while Paper B reports depression using Scale Y in the same participants at the same follow-up. If both effect estimates are entered into a conventional meta-analysis as if they came from two independent studies, the underlying trial may receive unintended extra influence.
By contrast, if Paper A reports depression and Paper B reports an eligible adverse-event outcome, both reports may contribute useful information to different outcome syntheses without duplicating participants within either synthesis.
Situation
Can Both Reports Be Useful?
Double-Counting Concern
Same participants, different eligible outcomes
Yes
Usually manageable when outcomes are synthesized separately
Same participants, same outcome, different instruments
Yes, but a selection or synthesis rule is needed
Potentially substantial if both are treated as independent estimates
Same participants, different follow-up times
Yes
Depends on whether time points enter separate or combined syntheses
One report analyzes a subgroup of the main sample
Potentially
Important if subgroup and full-sample estimates enter the same synthesis
Companion paper supplies only methodological information
Yes
No participant double-counting from using descriptive information alone
Do Not Confuse Data Extraction With Meta-Analytic Inclusion
You can extract information from a report without placing every number it contains into a meta-analysis. These are separate decisions.
For example, a subgroup paper may clarify treatment adherence or provide a relevant descriptive characteristic. You can use that information in the study record even if its subgroup effect estimate is not eligible for the primary quantitative synthesis.
This distinction is useful because an overly aggressive response to duplication can lead reviewers to discard informative reports merely to keep the dataset tidy. Methodological neatness is desirable, of course, but preferably not at the expense of actual information.
Map Which Participants Contribute to Which Result
When companion reports are complex, create a small outcome-by-report map. Record the participants, outcome, measurement instrument, time point, and analytic population behind each potentially eligible result.
Report Which publication contains the result?
Population Full randomized sample, complete cases, subgroup, or follow-up participants?
Outcome What construct or endpoint is being reported?
Time point When was the outcome measured?
Synthesis destination Which review outcome or analysis, if any, could this estimate enter?
This makes it easier to see whether two apparently different results are actually alternative measurements of the same outcome in the same people.
Prespecify Rules for Multiple Eligible Results
A study can report several eligible results for one outcome because of different instruments, subgroups, time points, or statistical summaries. Cochrane recommends specifying in the protocol how such multiplicity will be handled, rather than choosing among results after seeing which estimate is most favorable or convenient.
Depending on the review question, a protocol might specify preferred measurement instruments, clinically meaningful time windows, preferred analysis populations, or another defensible hierarchy. More complex synthesis methods may sometimes accommodate correlated estimates rather than requiring selection of only one, but the method must actually account for the dependence.
Different Follow-Up Times Require an Outcome-Time Framework
Companion papers frequently report later follow-up. Suppose the primary report provides a three-month outcome and another paper reports the same participants at 12 months. Both results may be relevant if your protocol defines short-term and long-term outcome windows.
They should not, however, silently become two independent studies. They are repeated observations from the same underlying investigation.
Subgroup Papers Require Participant-Level Awareness
A companion analysis might use only women, participants above a particular age, one study site, or participants with a particular baseline condition. If those people are already represented in a full-sample estimate, adding the subgroup estimate to the same analysis can count them again.
This is why you need to know whether two papers use the same participants and whether the samples constitute an overlapping study population .
Do Not Assume the Primary Report Is Correct Whenever Reports Disagree
Companion papers can expose inconsistencies. Sample sizes, event counts, outcome definitions, or effect estimates may differ across reports. Cochrane recommends planning how discrepancies across sources will be resolved and, where necessary, contacting investigators.
Sometimes the discrepancy is legitimate: the papers use different follow-up periods or analysis populations. Sometimes a later publication corrects an earlier value. Occasionally the available sources do not permit reconciliation. The appropriate response is investigation and documentation, not automatic deference to whichever publication you labeled primary.
Watch Out
“Use one paper per study” is not a safe rule. It can prevent duplicate estimates, but it can also throw away unique outcomes, follow-up information, harms, and methodological details. The better rule is to use all relevant reports while controlling which participant contributions enter each synthesis.
06 · What This Means for You
Track Reports Separately but Synthesize Participants Deliberately
A practical workflow is to maintain one study record with multiple linked report records. For every extracted result, preserve its source report, participant population, outcome, time point, and analysis type. Cochrane specifically recommends recording both study and report identifiers in data-collection systems when studies have multiple reports.
A simple decision framework
If a companion paper contains unique descriptive or methodological information
Use it to enrich the study record; this does not by itself double-count participants.
If it reports a different eligible outcome
Use the result in the appropriate outcome synthesis while retaining its connection to the same study.
If it reports the same outcome and time point in the same participants
Apply your prespecified selection rule or a method that appropriately handles dependent estimates.
If it reports a subgroup already contained in the full sample
Do not treat subgroup and full-sample estimates as independent contributions to the same synthesis.
If participant overlap cannot be determined
Record the uncertainty and investigate before assuming independence.
The aim is not to minimize the number of papers you use. It is to preserve the maximum relevant information while maintaining an accurate account of how many studies and participants actually generated it.
07 · A Quick Checklist
Before Using Data From a Companion Paper
For each companion report, check:
That the report has been linked to the correct underlying study.
Which participants or analytic population generated the reported result.
Whether those participants are already represented in another estimate being considered for the same synthesis.
Which outcome, measurement instrument, and follow-up time the report provides.
Whether the report contributes unique methods, harms, follow-up, or other information even if its effect estimate is not used.
Whether multiple eligible results require a prespecified selection rule or an analytical method that handles dependence.
Whether differences between reports have been reconciled or explicitly documented.
Whether both the study ID and source report remain traceable in your extraction records.
11 · Cite this Guide
How to Cite This Guide
This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.
Recommended (Field Guide)
APA
MLA
Chicago
Copy Citation